Back

Benefit of wearable cardioverter defibrillator in patients with end stage renal disease

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Renal failure and cardiovascular disease Renal Failure and Cardiovascular Disease ESC Premium Access ESC Congress 2018

About the speaker

Photo
Assistant Professor Ashley Burch

East Carolina University, Greenville (United States of America)

5 More presentations in this session

Presentation thumbnail
The clinical characteristics and outcomes of venous thromboembolism in patients with renal dysfunction: from the COMMAND VTE Registry
Doctor Y. Tsuyuki (Shimada, JP)
Abstract Slides
Presentation thumbnail
Myocardial ultrastructural changes in progressive CKD: the key intermediaries of 'uraemic' cardiomyopathy?
Doctor M. Hayer (Birmingham, GB)
Abstract Slides
Presentation thumbnail
Impact of proteinuria on cardiovascular outcomes in Japanese patients with atrial fibrillation: The Fushimi AF Registry
Doctor S. Ikeda (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Drug eluting are superior to bare metal stents in patients with end-stage renal disease on dialysis: a meta-analysis
Doctor V. Galiffa (Novara, IT)
Abstract Slides
Presentation thumbnail
Antiplatelet therapy in acute coronary syndrome associated with renal impairment. Real world data.
Doctor A. Izquierdo Bajo (Seville, ES)
Abstract Slides

Access the full session

Session thumbnail
Renal failure and cardiovascular disease

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources